1998:
Pharmacia Køge Chemicals changes name to pK Chemicals – PKC.
2000:
Mr. Lars Skov Ibsen (CEO) buys PKC from Amersham Pharmacia Biotech.
2001:
Other owners buy into PKC.
2003:
PKC acquires the product rights for DEAE-Dextran and Dextran Sulphate from Amersham Biosciences.
2005:
PKC acquires CM-Dextran from GE Healthcare Protein Separations.